Alivia Chaudhuri

Title: Alivia Chaudhuri: Innovator in Opioid Drug Formulation

Introduction

Alivia Chaudhuri is a notable inventor based in Cranbury, NJ (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of opioid drugs. Her innovative work focuses on creating safer and more effective drug delivery systems.

Latest Patents

Alivia holds a patent for "Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatings." This patent describes a sustained release formulation for opioid drugs, which includes an opioid-ion exchange resin complex with a hybrid coating. The hybrid coating consists of a cured polyvinylacetate polymer and a pH-dependent enteric coating layer mixed therein. The patent also outlines methods for making and using this formulation, highlighting its potential to improve patient safety.

Career Highlights

Alivia Chaudhuri is currently employed at Tris Pharma, Inc., where she continues to advance her research in drug formulation. Her work is pivotal in addressing the challenges associated with opioid medications, particularly in reducing the potential for abuse.

Collaborations

Alivia collaborates with talented colleagues such as Ketan Mehta and Yu-Hsing Tu, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical sciences.

Conclusion

Alivia Chaudhuri's contributions to opioid drug formulation exemplify her commitment to improving healthcare through innovation. Her patent and ongoing work at Tris Pharma, Inc. reflect her dedication to creating safer medication options for patients.